At FHI Clinical, our mission is to achieve maximum social impact through the support and development of life-saving vaccines and medicines — for everyone. Key to this is equitable and representative access to clinical research, something we have discussed in previous blog posts and articles.  Including participants representative of the population who will benefit most from a vaccine or drug helps ensure safety and efficacy for everyone as well as opportunities to benefit from the care provided during clinical research. Moreover, regulatory agencies such as the U ..read more

This Site and Investigator Spotlight introduces Dr. Lucas Tina, who is affiliated with the Victoria Biomedical Research Institute (VIBRI) and Kenya Medical Research Institute (KEMRI) in Kisumu, Kenya. Dr. Tina serves as a Scientific Advisory Expert for FHI Clinical, and VIBRI and KEMRI are listed in FHI Clinical’s database of research sites, and we are currently working with the sites on vaccine studies for pneumonia, malaria drug trials, tuberculosis surveillance and investigating the outcomes of sepsis. Dr. Tina and VIBRI were spotlighted in April 2023, and all information on this page is ..read more

This Site and Investigator Spotlight introduces Tariro Makadzange, MD, PhD, from the Charles River Medical Group, Pvt, Ltd (CRMG), in Harare, Zimbabwe. CMRG is listed in FHI Clinical’s database of research sites, and we look forward to working with Dr. Makadzange’s team in the future on research projects that align with their capabilities and the local epidemiology and healthcare needs. Dr. Makadzange and CMRG were spotlighted in January 2023, and all information on this page is current as of then. ABOUT DR. MAKADZANGE ABOUT CRMG ABOUT ZIMBABWE'S HEALTH PRIORITIES About Dr. Makadzang ..read more

This Site and Investigator Spotlight introduces Nsengi Ntamabyaliro, MD, MSc, from the Unit of Clinical Pharmacology and Pharmacovigilance (UPC-PV), University of Kinshasa, in Kinshasa, Democratic Republic of the Congo (DRC). FHI Clinical has worked with Dr. Ntamabyaliro on Phase 3 and 4 trials since 2007, at which time there was a focus on research capacity development in the DRC. Based on this history, FHI Clinical and Dr. Ntamabyaliro are currently collaborating with the UPC-PV on vaccine clinical trials and are working to identify opportunities to keep the research team active at the UPC ..read more

Anine Ungerer, Associate Director, Human Resources, began her career in law in 2014, after her graduation from the University of Pretoria in South Africa. She completed a six-week rotation at the deeds and local municipality offices to support drafting purchase agreements and transfer documents but quickly realized that the slow pace of the office was not for her. “It was a risky move in a country with an unemployment rate of 24% at that time, but I still consider this one of the best career decisions I have ever made,” Ungerer said. She joined a family law firm soon after. There, Ungerer wo ..read more

Aimy Palawooth was in her third year working for a pharmaceutical company in Bangkok, Thailand, when a friend invited her to apply to an organization called FHI 360. “She called me and said, ‘Hey Aimy, I found this job, and I don’t think it’s suitable for me, but I think this is you,’” said Palawooth. After perusing the FHI 360 job description online, she was intrigued. For Palawooth, the requirement of traveling more than 50% of the hours was one of the attractive benefits of the position, especially due to her location in Thailand. “From Asia, travel to different countries is a bit far, s ..read more

Prior to joining FHI Clinical in November 2022, Andy had spent six years in the clinical research industry, with roles ranging from operations to business development. Most recently, Andy was part of the inside sales team at a large CRO. During his time in their team, he oversaw several strategic internal initiatives and mentored new team members. Play Video Based in North Carolina, Andy works hard to build lasting relationships with his colleagues and clients and strives to help make a difference with the projects he supports. Andy has bachelor’s degrees in Biology and Exercise and Sport S ..read more

Ensuring health equity has long been key to the mission of FHI 360, our parent company. One reason that FHI 360 formed a specific clinical trials subsidiary, FHI Clinical, was the recognition that equity in research plays a vital role in equity in health and health care, and that has underpinned our mission since we formed FHI Clinical in 2019. Equity in research is essential for a number of reasons. First, because the efficacy of therapies and vaccines depend on many intrinsic and extrinsic factors, the clinical trial population must reflect the characteristics of the product’s end user in ..read more

“I have a non-traditional career path, which makes me interested in other people who have non-traditional paths,” Nathan McKinney, Associate Director, Proposal Management, said. “I’m interested in what people bring from different areas of their lives.” Cultivating experience McKinney began working for FHI 360 in 2016, after 10 years of proposal management work at RTI International, a nonprofit organization local to the Research Triangle. When Global Research Services (GRS) at FHI 360 began to transition to FHI Clinical, McKinney was contacted to be a part of the team. For McKinney, the answe ..read more

Watch this episode of The Huxley Morton Podcast to hear our COO Rob King talk about how the skills he learned as a law enforcement officer working in the hostage and drug department help him excel in the clinical research industry. Play Video The post Meet Rob King, Chief Operating Officer appeared first on FHI Clinical ..read more